Company news
Shandong Buchang Pharmaceuticals Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Providing Guarantee for Holding Subsidiary
May 28, 2026
Announcement on Providing Guarantee for Wholly-owned Subsidiary
May 26, 2026
Announcement on the Change of Business Scope of Wholly-owned Subsidiary
May 25, 2026
Announcement on Progress in Holding Subsidiary's Proposed Signing of Intellectual Property Cooperation Agreement
May 19, 2026
Announcement on the Change of Domicile of Holding Subsidiary
May 14, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 13, 2026
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
May 12, 2026
Announcement on Progress in the Proposed Transfer of Holding Subsidiary Equity
May 11, 2026
Announcement on Receipt by its Holding Subsidiary of the Notice of Grant for the 2026 Project under the National Science and Technology Major Project for Prevention and Control of Emerging, Re-emerging and Major Infectious Diseases
May 8, 2026
Announcement on Change of Drug Production License of the Company and Wholly-owned Subsidiary
April 28, 2026
Announcement on 2025 Final Profit Distribution and Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Prepare the 2026 Interim Dividend Plan
April 27, 2026
Announcement on Obtaining Malaysian Drug Registration Certificate for Yangzhengheji Decoction
April 8, 2026
Announcement on Resolutions of the 46th Meeting of the 5th Board of Directors
April 7, 2026
Announcement on the Transfer of Holding Subsidiary Equity
March 12, 2026
Announcement on Participation in the Auction for the Qualification as a Restructuring Investor and Its Results
February 25, 2026
Announcement on Partial Drugs of the Subsidiary Being Selected for National Procurement Continuation After the Expiry of Agreement
February 11, 2026
Announcement on Pledge Release and Re-pledge of Partial Shares Held by Controlling Shareholder
February 10, 2026
Announcement on Resolutions of the 43rd Meeting of the 5th Board of Directors
February 9, 2026
Announcement on Progress in Proposed Waiver of Preemptive Rights for Equity of Holding Subsidiary and Related Party Transactions
February 4, 2026
Announcement on Wholly-owned Subsidiary Completing Industrial and Commercial Change Registration
February 2, 2026
Earnings Preannouncement for 2025
January 27, 2026
Announcement on the Plan of Share Repurchase through Call Auction and Obtaining of Commitment Letter on Special Loan for Repurchase from Financial Institution
January 16, 2026
Announcement on Holding Subsidiary Completing Industrial and Commercial Change Registration
January 7, 2026
Indicative Announcement on Changes in Fair Value of Trading Financial Assets
January 6, 2026
Announcement on the Recognition of Wholly-owned Subsidiary as a High-tech Enterprise Again
January 5, 2026
Announcement on Pledge of Controlling Shareholders' Shares
December 30, 2025
Announcement on the Execution of an Exclusive Supply Agreement between Holding Subsidiary Luzhou Buchang and MEDISPEC
December 29, 2025
Announcement on the Proposed Execution of a Technology Transfer Agreement by Wholly-owned Subsidiary Shandong Danhong with Shaanxi Functional Food Engineering Center Co., Ltd.
December 24, 2025